High Levels Of Release Research Articles

Tocilizumab: A Therapeutic Option for the Treatment of Cytokine Storm Syndrome in COVID-19

Presently, we need more therapeutic molecules for this COVID-19 outbreak. The severity and mortality of the disease is associated with a high level of release of cytokine in the patients which is known as CRS (cytokine release syndrome) or cytokine storm syndrome. IL-6 is a type of pro-inflammatory cytokine which release in the severe COVID-19 patients. This cytokine initiates CRS the JAK-STAT or MAPK/NF-κB-IL-6 pathway. Tocilizumab, a humanized monoclonal antibody, is designed to bind both mIL-6R (membrane bound receptor for IL-6) and sIL-6R (soluble receptor for IL-6) and inhibit the JAK-STAT or MAPK/NF-κB-IL-6 signaling pathway. It finally stops the cytokine storm syndrome. However, we need to understand that how tocilizumab is bound with mIL-6R or sIL-6R. Similarly, we also need to understand more about the real molecular mechanism of activity of tocilizumab.

Toxicological effects of AgNPs on duckweed (Landoltia punctata)

Silver nanoparticles (AgNPs) are widely applied in several types of products since they act as a biocide. However, their high level of release into the environment can bring risks to ecosystems. Thus, the toxicity of AgNPs toward duckweed (Landoltia punctata) was investigated by monitoring the growth rate inhibition and the effect on the photosynthetic metabolism through morphological and ultrastructural analysis. The AgNPs were characterized by transmission electron microscopy and the effective diameter (dynamic light scattering) and zeta potential were determined. Plants were grown according to the environmental conditions recommended in ISO/DIS 20079 and then exposed to different concentrations of AgNPs. Inhibition of the growth rate was measured based on the EC50 and changes in the morphology, cellular structures and photosynthetic pigments were evaluated along with the silver accumulation. Although the results showed low growth inhibition when compared to other studies, significant damage to the ultrastructure, decreases in the photosynthetic pigments and starch grains, an increase in the phenolic compounds and physiological changes, such as a loss of color, were observed. Moreover, the accumulation of silver ions was noted and this could lead to bioamplification in consumer organisms, since duckweed belongs to the first level of the food chain.

High Constitutive Cytokine Release by Primary Human Acute Myeloid Leukemia Cells Is Associated with a Specific Intercellular Communication Phenotype.

Acute myeloid leukemia (AML) is a heterogeneous disease, and this heterogeneity includes the capacity of constitutive release of extracellular soluble mediators by AML cells. We investigated whether this capacity is associated with molecular genetic abnormalities, and we compared the proteomic profiles of AML cells with high and low release. AML cells were derived from 71 consecutive patients that showed an expected frequency of cytogenetic and molecular genetic abnormalities. The constitutive extracellular release of 34 soluble mediators (CCL and CXCL chemokines, interleukins, proteases, and protease regulators) was investigated for an unselected subset of 62 patients, and they could be classified into high/intermediate/low release subsets based on their general capacity of constitutive secretion. FLT3-ITD was more frequent among patients with high constitutive mediator release, but our present study showed no additional associations between the capacity of constitutive release and 53 other molecular genetic abnormalities. We compared the proteomic profiles of two contrasting patient subsets showing either generally high or low constitutive release. A network analysis among cells with high release levels demonstrated high expression of intracellular proteins interacting with integrins, RAC1, and SYK signaling. In contrast, cells with low release showed high expression of several transcriptional regulators. We conclude that AML cell capacity of constitutive mediator release is characterized by different expression of potential intracellular therapeutic targets.

Ecotin-like serine peptidase inhibitor ISP1 of Leishmania major plays a role in flagellar pocket dynamics and promastigote differentiation.

Leishmania ISPs are ecotin-like natural peptide inhibitors of trypsin-family serine peptidases, enzymes that are absent from the Leishmania genome. This led to the proposal that ISPs inhibit host serine peptidases and we have recently shown that ISP2 inhibits neutrophil elastase, thereby enhancing parasite survival in murine macrophages. In this study we show that ISP1 has less serine peptidase inhibitory activity than ISP2, and in promastigotes both are generally located in the cytosol and along the flagellum. However, in haptomonad promastigotes there is a prominent accumulation of ISP1 and ISP2 in the hemidesmosome and for ISP2 on the cell surface. An L. major mutant deficient in all three ISP genes (Δisp1/2/3) was generated and compared with Δisp2/3 mutants to elucidate the physiological role of ISP1. In in vitro cultures, the Δisp1/2/3 mutant contained more haptomonad, nectomonad and leptomonad promastigotes with elongated flagella and reduced motility compared with Δisp2/3 populations, moreover it was characterized by very high levels of release of exosome-like vesicles from the flagellar pocket. These data suggest that ISP1 has a primary role in flagellar homeostasis, disruption of which affects differentiation and flagellar pocket dynamics.

Time course of release of inflammatory markers after coronary stenting: comparison between bare metal stent and sirolimus-eluting stent

High levels of release of inflammatory markers after coronary angioplasty are predictors of late restenosis. Sirolimus-eluting stent reduces the risk of restenosis. To compare the release of inflammatory markers after coronary angioplasty with sirolimus-eluting stent and bare metal stent. Sixteen patients with a proximal left anterior descending coronery artery stenosis were randomly assigned to receive either bare metal stent (n = 8) or sirolimus-eluting stent (n = 8). We measured simultaneously aortic and coronary sinus concentrations of the von Willebrand factor antigen, tumor necrosis factor-alpha and interleukin-6 before, immediately and after 2 h after stenting. High-sensitivity C-reactive protein and troponin-I circulating levels were measured before and 6 and 24 h after coronary angioplasty. Before stenting, all values were similar in both groups. The coronary sinus change of the von Willebrand factor antigen level between baseline and 2 h after stenting was + 20.1 +/- 26.9% in the bare metal stent group and -5.7 +/- 23.02% in the sirolimus-eluting stent group (P < 0.05). We observed a significant increase in the von Willebrand factor antigen (from 132.8+/-58.8 to 169 +/- 40.7%, P < 0.05) systemic concentrations 24 h after stenting in the bare metal stent group but not in the sirolimus-eluting stent group (from 140.6+/-84% to 136 +/- 39.5%), P = NS). The present study shows that a difference in the release of inflammatory markers can be detected after coronary stenting with bare metal stent or sirolimus-eluting stent. The lower release of the von Willebrand factor antigen in the coronary sinus 2 h after the procedure and the lower systemic concentrations of the von Willebrand factor antigen 24 h after stenting in the sirolimus-eluting stent group are likely to reflect a reduced production of the von Willebrand factor antigen at the site of the vascular injury.

Effectiveness of hydroxyapatite-vancomycin bone cement in the treatment of Staphylococcus aureus induced chronic osteomyelitis

In the field of local application of antimicrobials, a number of novel drugs and/or new drug delivery systems have been developed in recent years. The present study aimed to investigate hydroxyapatite cement (HAC) as a carrier for vancomycin in the treatment of chronic osteomyelitis due to Staphylococcus aureus strains with various mechanisms of resistance. The release of vancomycin from standard test cylinders was determined in vitro and the efficacy of the delivery system was measured in vivo using a rabbit model of chronic osteomyelitis. First, powdered HAC was mixed with vancomycin at 80, 160 and 240 mg/g. After hardening, formed cylinders were eluted in phosphate buffer and antibiotic release was measured by agar diffusion. High levels of release (1512±318 to 1937±336 μg/ml) were obtained for 12 to 20 days depending on the dosage of vancomycin. Additionally, bone infection was induced in the tibia of 30 New Zealand white rabbits by injecting either a methicillin-resistant S. aureus strain (MRSA) or a S. aureus strain with a small colony variant (SCV) phenotype. After 3 weeks (chronic infection), all animals were treated by debridement. Moreover, group 1 (challenged with SCVs) and group 2 (challenged with MRSA) were treated by filling the marrow with HAC alone, whereas in groups 3 (SCVs) and 4 (MRSA) the marrow was filled with HAC/vancomycin (160 mg/g). After 6 weeks all animals were sacrificed. At 3 weeks, pathogens were detected in 24 of 30 animals. All swabs of the control groups, positive for S. aureus on day 21, were also positive on day 42 and S. aureus strains recovered were shown to be clonal to the strains used for induction of osteomyelitis. By contrast, no growth was found in the treatment group following 7 days of incubation in BHI bouillon. HAC/vancomycin-treated animals showed no histological evidence of infection on day 42. In the other groups, different stages of chronic osteomyelitis were found histologically. No local or systemic side effects due to HAC or vancomycin were seen. HAC is an effective carrier material for antibiotic compounds even in refractory infections due to MRSA or S. aureus SCVs.

Investigation of the solubility and ion release in the glass system K 2O–Na 2O–CaO–P 2O 5

Glasses from the quaternary glass system K 2O–Na 2O–CaO–P 2O 5 were produced by standard glass forming techniques. The compositions were limited by fixing the P 2O 5 at 45 mol%, fixing the CaO content at either 20, 24 or 28 mol%. The K 2O and Na 2O made up the residual varying from 0 to 25 mol% K 2O. General trends showed that with increasing CaO content, the glasses showed a decrease in solubility as expected. For a single system of fixed CaO content, with increasing K 2O content, there was an increase in solubility. This was seen at all three CaO contents. All the glasses showed an initial increase in pH followed by a gradual decrease with time and this was accounted for by the initial release of Na + ions into solution. For the ion release curves, for all fixed CaO contents, the glass with 0 mol% K 2O showed the lowest Ca 2+ release. This was accounted for as being due to the low solubility compared to the K 2O containing glasses. The Na + release appeared anomalous, as it was higher than all the K 2O containing glasses. Even though the glasses with 0 mol% K 2O showed the lowest solubility, the amount of Na + contained in the glass was high, hence the high levels of release.

Protein and platelet interactions with thermally denatured fibrinogen and cross-linked fibrin coated surfaces

In this work the hypothesis that a mature, cross-linked fibrin clot, pre-formed on a biomaterial, may be relatively nonthrombogenic was investigated. A cross-linked fibrin layer was formed on polyethylene which had been precoated with thermally denatured fibrinogen. Plasma protein adsorption and platelet interactions with the cross-linked fibrin and denatured fibrinogen surfaces were investigated. The adsorption of albumin, fibrinogen, and fibronectin from plasma was measured. For all three proteins, the cross-linked fibrin surface exhibited much higher levels of adsorption than either the thermally denatured fibrinogen or the polyethylene surface. Vroman peaks were observed for fibrinogen and fibronectin on polyethylene but not on the cross-linked fibrin and thermally denatured fibrinogen materials. In dilute plasma the thermally denatured fibrinogen surface showed considerable resistance to protein adsorption. However, at plasma concentrations greater than about 5% normal, this protein resistance was apparently lost. Platelet interactions (adhesion and release of granule constituents from adherent platelets) using suspensions of washed platelets in the presence of red cells were investigated at shear rates of 50, 300, and 525 s -1 using a cone and plate apparatus. The levels of platelet adhesion on the different surfaces were in the order: adsorbed fibrinogen>cross-linked fibrin>thermally denatured fibrinogen=polyethylene. Platelets on the cross-linked fibrin surface also showed high levels of release indicating significant platelet activation. Scanning electron microscopic observations were in agreement with the platelet adhesion and release data, showing only a few (but well-spread) adherent platelets on the cross-linked fibrin surface.

Factors determining more efficient large-scale release of a periplasmic enzyme from E. coli using lysozyme

Large scale use of lysozyme for periplasmic release has been impeded by the cost of the pure enzyme and its subsequent presence as a contaminant in later downstream processing steps. In this paper, we discuss the use of lysozyme for pilot scale recovery of a periplasmic enzyme from E. coli. The effects of concentration of sucrose, lysozyme and cells on periplasmic enzyme release were examined. Lysozyme concentration can be reduced 5-fold from previous reports and a reduction in sucrose concentration from 20 to 15% (w/v) allows an improvement in centrifugal harvesting by reducing viscosity. High levels of release were still achieved using this technique and further improvements in yield were obtained by optimising other components of the releasing mixture. Results show that some release is still achieved in circumstances where no lysozyme use is possible. Results also indicate that a substantial proportion (up to 70%) of lysozyme remains bound to the cellular debris after its action and is removed with this material.

Effects of R(−)-1-(benzo[ b]thiophen-5-yl)-2-[2-( N, N-diethylamino) ethoxy]ethanol hydrochloride (T-588), a novel cognitive enhancer, on noradrenaline release in rat cerebral cortical slices

We investigated the effects of R(−)-1-(benzo[ b]thiophen-5-yl)-2-[2-( N, N-diethylamino) ethoxy]ethanol hydrochloride (T-588), a novel cognitive enhancer, on noradrenaline (NA) release from rat cerebral cortical slices in vitro. Addition of T-588 in an assay mixture stimulated [ 3H]NA release from prelabeled slices in the presence or absence of extracellular CaCl 2, and in the presence of the Ca 2+/calmodulin antagonists N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide and trifluoperazine. T-588 stimulated NA release with a time lag of about l min, and the high level of release was maintained for at least 10 min, whereas maximal KCl-evoked NA release was observed within l min after the addition of KCl, and the effect declined subsequently. The effect of T-588 was reversible (pretreatment with T-588 showed no effect on NA release after two washes by centrifugation). We also compared the effects of T-588 and N-ethylmaleimide (NEM), a sulfhydryl alkylating agent known to stimulate neurotransmitter release in several types of cells. The addition of NEM stimulated NA release irreversibly from the slices in a Ca 2+-independent manner, and the effect of NEM, but not that of T-588, was inhibited by the simultaneous addition of dithiothreitol, a sulfhydryl group reducing agent. The addition of T-588, which stimulated NA release by itself, inhibited the NA release by 0.6 mM NEM, although the effect of T-588 was additive in the presence of 0.2 mM NEM. These findings suggest that T-588 stimulates NA release from rat cerebral cortical slices in a Ca 2+- and calmodulin-independent manner, possibly via an NEM-sensitive factor(s), although the mechanism of the effects of T-588 seems to be different from that of NEM.

Effect of glycerol treatment on transmitter release at the frog neuromuscular junction

Exposure of frog skeletal muscle to a Ringer solution made hyperosmotic with glycerol, followed by return of the preparation to a normal Ringer, results in an irreversible uncoupling of the mechanical activity of the muscle. This technique for preventing muscle contraction has often been used to study neuromuscular transmission under normal or high levels of release without inteference from muscle contraction. Little was known, however, about the effects of glycerol treatment on the process of transmitter release. In this paper we report the results of a study in which we examined the effects of glycerol treatment on transmitter release during repetitive stimulation at the frog sartorius neuromuscular junction. We found that glycerol treatment altered the stimulation-induced changes in end-plate potential (EPP) amplitude normally observed during repetitive stimulation at this synapse. This effect, which increased progressively with time for up to 8 h following removal of glycerol, could be accounted for by presynaptic changes in the amount of transmitter released.

Synergistic effects of calcium‐mobilizing agents and adenosine on histamine release from rat peritoneal mast cells

1. Adenosine and its metabolically stable analogue N-ethyl-carboxamidoadenosine (NECA) enhance histamine release from rat peritoneal mast cells when these are stimulated by calcium-mobilizing agents. NECA and adenosine shift the concentration-response curve of the calcium ionophore A23187 to lower concentrations. 2. The potencies of NECA or adenosine in enhancing A23187-induced histamine release are dependent on the level of stimulated release in the absence of adenosine analogues. At high levels of release their potencies are up to 20 times higher than at low levels. Consequently, averaged concentration-response curves of adenosine and NECA for enhancing histamine release are shallow. 3. The adenosine transport blocker S-(p-nitrobenzyl)-6-thioinosine (NBTI) has no effect by itself at low levels of stimulated histamine release, but abolishes the enhancing effect of adenosine. At high levels of release, however, NBTI alone enhances the release of histamine. 4. It is concluded that adenosine and calcium reciprocally enhance the sensitivity of the secretory processes to the effects of the other agent. The levels of intracellular adenosine obtained by trapping adenosine inside stimulated mast cells are sufficient to enhance histamine release substantially, suggesting that this effect may play a physiological and pathophysiological role.

Dependence of spontaneous release at frog junctions on synaptic strength, external calcium and terminal length.

1. The calcium dependence of spontaneous transmitter release from nerve terminals of different lengths was examined at neuromuscular junctions in frog muscle. Miniature endplate potential (MEPP) frequency was positively correlated with the endplate potential (EPP) quantal content and was dependent on external Ca2+. The higher the resting MEPP frequency in a 0.25 mM-Ca2+ Ringer solution, the greater the dependence on external Ca2+. MEPP frequency in all terminals dropped to approximately the same low level in a Ca2(+)-free Ringer solution containing EGTA. This suggests that terminals with higher release levels have a larger Ca2+ influx at rest. 2. Several tests were done to try to characterize the mode of Ca2+ entry into resting terminals. omega-Conotoxin (omega-CgTx) blocked evoked release and reduced MEPP frequency, but not as effectively as zero Ca2(+)-EGTA Ringer solution. Some component of Ca2+ influx thus appears to enter through channels insensitive to omega-CgTx. Tetrodotoxin (TTX) did not affect MEPP frequency, indicating that the Ca2+ did not enter through TTX-sensitive Na+ channels that might be opening spontaneously at rest. Hyperpolarization of the terminal by reducing the K+ in the Ringer solution caused no consistent differences in MEPP frequency, suggesting that the Ca2+ influx is relatively insensitive to small changes in membrane potential around the resting level. Strong buffering of the Ringer solution with citrate, to overwhelm any differences in Ca2+ buffering within different junctional clefts, had no significant effect on the MEPP frequency. 3. Evidence that the Na(+)-Ca2+ exchanger helps set the internal Ca2+ level was obtained. Reduction of the Na+ concentration in the Ringer solution caused increases in MEPP frequency ranging from 6 to 440%. However, these changes were not correlated with resting MEPP frequency, hence differences in MEPP frequency probably are not the result of differences in Na(+)-Ca2+ exchanger function in terminals having a uniform Ca2+ leak. 4. Although MEPP frequency was generally correlated with quantal content, in subsets of junctions grouped according to their similar quantal contents, there was a positive correlation between MEPP frequency and terminal length. 5. In zero Ca2(+)-EGTA Ringer solution, the low residual MEPP frequency is independent of terminal length, even when MPP frequency is sharply increased by tetanic stimulation.

Fenoterol, a selective beta2‐adrenergic agonist, and inhibition of IgE‐mediated basophil histamine release

The present study was undertaken to evaluate the effect of fenoterol, a selective beta 2-adrenergic agonist, on basophil histamine release. Fenoterol at 10(-7) to 10(-3) M did not inhibit the release of histamine induced by Dermatophagoides farinae extract (D.f.) from leukocytes from allergic patients sensitive to mite. Similarly, there was no suppression of histamine release induced by anti-IgE and formyl-methionyl-leucyl-phenylalanine under the influence of fenoterol. Fenoterol caused a slight inhibition of the calcium ionophore A23187-induced histamine release at 10(-3) M with % inhibition of 11.8 +/- 2.4 (means +/- SEM, P less than 0.05). There was no synergism between fenoterol and theophylline in inhibiting D.f.-induced histamine release. Fenoterol did not suppress the release of histamine induced by antigen at low as well as high levels of release. Based on the data on the effect of fenoterol on IgE-mediated histamine release, it was concluded that in contrast to a human lung mast cell system, the beta-adrenergic receptor-adenylate cyclase system is not a control mechanism in IgE-mediated basophil histamine release.

Histamine secretion induced byN-acetyl cysteine

The mucolytic drug N-acetyl cysteine has been shown to release histamine from cultured mouse mast cells and from human basophils. At neutral pH the release was moderate and non-cytotoxic. If the acidity of the drug was not neutralized, this histamine release was markedly potentiated, but was then associated with a reduction in the viability of the cells. However, the high level of release could not be reproduced by simply exposing the cells to an acidic medium. The results are discussed in terms of a possible mechanism for the adverse reactions sometimes observed during N-acetyl cysteine therapy.

Ultrastructural correlates of naturally occurring differences in transmitter release efficacy in frog motor nerve terminals.

Motor nerve terminals in cutaneous pectoris muscles of the frog Rana pipiens release more transmitter and form synapses with higher levels of effectiveness than do those in sartorius muscles. Neuromuscular junctions from these two muscles were compared in the electron microscope to search for ultrastructural correlates of differences in transmitter release and synaptic effectiveness. The following measurements were made from cross-sections of junctions with known levels of effectiveness: (a) the presence of active zones, the presumed sites of transmitter release, (b) active zone size, (c) the perimeter, cross-sectional area, height and width of nerve terminals, (d) number of mitochondria, (e) vesicle density, and (f) the extent to which Schwann cells wrap terminals. Nerve terminals in the two muscles did not differ in size, shape or vesicle density. The more strongly releasing cutaneous pectoris terminals did, however, have significantly larger active zones due to deeper invagination of the terminal into the postsynaptic gutter and lesser interposition of Schwann cell processes between presynaptic and postsynaptic membranes. Cutaneous pectoris terminals also contained more mitochondria, presumably to supply the greater energy demand imposed by high release levels.

Profiles of evoked release along the length of frog motor nerve terminals.

In order to determine the relative probability of evoked transmitter release from different parts of frog motor nerve terminals, a technique has been developed in which single quantum end-plate potentials (e.p.p.s) are recorded by two intracellular electrodes, located at opposite ends of identified junctions. The log of the ratio of the amplitudes recorded simultaneously at the two electrodes is a linear function of the distance of the site of origin of the event from each of the two electrodes. Using online computer data acquisition and analysis, and current pulses at known locations for spatial calibration, it is possible to localize the site of single quantum e.p.p.s to within +/- 10-20 micron. Using the frog cutaneous pectoris neuromuscular preparation and a low calcium, high magnesium Ringer solution to ensure mostly single quantum events and failures, several thousand responses were recorded from each junction, allowing construction of a profile of the numbers of single quantum events arising from each portion of the junction. By comparison of junctional morphology and release profiles, it is possible to construct a probability of release per unit length profile for the entire junction. This technique has several advantages over localization of release events by measurements of extracellular synaptic currents. It was found that, for most junctions, the central 60-90% of the terminal exhibited relatively uniform probability of release, with highest levels typically near the point where the axon first contacted the muscle fibre, or in regions with many short terminal branches. However, no instances have been found in which a small region of terminal (10% or less) showed extraordinarily high release levels (30-50% of the total release from the junction). Characteristically, but not invariably, there is reduced release near the ends of terminal branches, especially the longer branches, where release per unit length could be as little as 5-10% of that in proximal portions. Some junctions had large regions of terminal that released very little transmitter. These also showed multiple myelineated axonal inputs, and may have been polyneuronally innervated junctions in which one of the inputs was much weaker than the other.

Inverse relationship between transmitter release and terminal length in synapses on frog muscle fibers of uniform input resistance

Transmitter release at frog neuromuscular junctions is known to be related positively to nerve terminal length. However, the correlation is inexact, with a wide scatter of data. We have analyzed the endplate potentials (EPPs) of identified frog cutaneous pectoris muscle fibers, correlating release with terminal size and fiber input resistance (Rin). Transmitter release was assayed by quantal analysis of endplate activity in low Ca2+ Ringer solution and by measurement of the EPPs evoked in normal Ringer solution and curare. For fibers of approximately the same Rin, there is an inverse relationship between the level of transmitter release per unit length and total terminal length. Terminals with high levels of release per unit length tend to be shorter than do those which release relatively less transmitter per unit length. Furthermore, if the analysis is restricted similarly to fibers with nearly identical Rin, the total transmitter release of the largest endplates is usually less than that of the shorter terminals in the sample. These findings do not contradict the overall trend of greater release and longer terminals on larger muscle fibers (with lower Rin). Instead, they help explain the variability in measurement of release versus terminal length. The relationship that we find is consistent with the hypothesis that, in the cutaneous pectoris, terminals are induced to grow until an adequate safety factor for transmission is achieved.

Comparative study of the release of glutamate and GABA, newly synthesized from glutamine, in various regions of the central nervous system

The in vitro release of [ 3H]glutamate and [ 3H]γ-aminobutyric acid, both newly synthesized from [ 3H]glutamine, were studied in various regions of the rat and pigeon brain. The amount of transmitter released from slices during stimulation by excess K +, as well as the ratio of the amounts of glutamate and γ-aminobutyrate released, varied considerably from region to region. Very high levels of release of glutamate were observed in rat striatum and in rat and pigeon hippocampus whereas only moderate release of glutamate was found in rat and pigeon cerebellum, rat cochlear nucleus and rat substantia nigra. The highest levels of release of γ-aminobutyrate were observed in the rat substantia nigra, hippocampus and striatum. Particularly low levels of release of glutamate was observed in the pigeon optic tectum. The release of γ-aminobutyrate and glutamate in all structures was largely calciumdependent. These results suggest that the release of glutamate and γ-aminobutyrate newly synthesized from glutamine reflects the neurotransmitter function of the two amino acids within various CNS regions. They further suggest that the glutamate synthesizing and releasing pool is different from the γ-aminobutyrate synthesizing and releasing pool. The similarity between the release of glutamate in rat and pigeon cerebellum and hippocampus suggest some structural homology in both species.

Binomial analysis of quantal transmitter release at glycerol treated frog neuromuscular junctions.

1. Transmitter release was analysed at frog neuromuscular junctions pre-treated with 400 mM glycerol Ringer. In the absence of added drugs, end-plate potentials (e.p.p.s) and miniature e.p.p.s (m.e.p.p.s) could be recorded at selected junctions. 2. E.p.p.s were unusually large and calculations of quantal content indicated a high level of release. Also recorded were anomalous action potentials resembling e.p.p.s but these could be distinguished using a summation test. 3. Plots of coefficient of variation of e.p.p.s (0-5 Hz stimulation) versus direct quantal content (M1) showed a marked deviation from Poisson expectations with high M1. Analysis of these results with amplitude-frequency histograms showed a progressively better fit to binomial predictions with increasing M1. 4. The use of binomial statistics allowed direct calculations of the mean probability of release (p) and the readily available store (n). Increasing Ca/Mg caused increases in both n and p. 5. Plots of M1 vs. Ca/Mg showed a power relationship of 3.58. Maximum m.e.p.p. amplitude occurred at control Ca/Mg. Both results were consistent with studies in muscles not treated with glycerol and indicated that glycerol treatment caused no major alterations pre- or post-junctionally. 6. Estimates of quantum size using Poisson assumptions showed an over-all increase when stimulus frequency was raised, indicating a shift from binomial to a Poisson distribution. 7. The combined findings demonstrate that the glycerol treated preparation can be used to examine the release process during high output. Such release conforms to binomial statistics and allows direct determinations of the parameters n and p.